1747-597x

Substance Abuse Treatment Prevention and Policy

Springer (Biomed Central Ltd.)

View prefix report (10.1186)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 757 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact757 DOIs
2

Add abstracts to 576 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact576 DOIs
3

Add license metadata to 213 records

License metadata tells indexers and readers how each article may be reused.

Low impact213 DOIs

DOIs for this ISSN

Showing the top 5 of 1066 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Cultural interventions to treat addictions in Indigenous pop… (10.1186/1747-597x-9-34)
Abstract ORCID License
159.53 133
2 Effectiveness of school-based preventive interventions on ad… (10.1186/1747-597x-9-48)
Abstract ORCID License
150.00 99
3 Strategies to facilitate integrated care for people with alc… (10.1186/s13011-017-0104-7)
Abstract ORCID License
149.34 97
4 Global cocaine intoxication research trends during 1975–2015… (10.1186/s13011-017-0090-9)
Abstract ORCID License
145.84 87
5 The aetiology and trajectory of anabolic-androgenic steroid… (10.1186/1747-597x-9-27)
Abstract ORCID License
142.32 78
6 The efficacy of a blended motivational interviewing and prob… (10.1186/s13011-015-0042-1)
Abstract ORCID License
139.75 72
7 Gender differences in subjective discontinuation symptoms as… (10.1186/1747-597x-9-39)
Abstract ORCID License
138.38 69
8 Substance use disorders in Arab countries: research activity… (10.1186/1747-597x-9-33)
Abstract ORCID License
135.97 64
9 Substance use and risky sexual behaviours among street conne… (10.1186/1747-597x-9-45)
Abstract ORCID License
135.97 64
10 Systemic and individual factors in the buprenorphine treatme… (10.1186/s13011-016-0085-y)
Abstract ORCID License
134.95 62
11 Community pharmacists’ experiences in mental illness and add… (10.1186/s13011-016-0050-9)
Abstract ORCID License
130.53 54
12 PrEP in substance abuse treatment: a qualitative study of tr… (10.1186/1747-597x-10-1)
Abstract ORCID License
128.70 51
13 The pattern of substance use disorder in the United Arab Emi… (10.1186/s13011-016-0062-5)
Abstract ORCID License
128.07 50
14 A universal harm-minimisation approach to preventing psychos… (10.1186/1747-597x-9-24)
Abstract ORCID License
126.09 47
15 Recruitment to doping and help-seeking behavior of eight fem… (10.1186/s13011-016-0056-3)
Abstract ORCID License
126.09 47
16 Lead poisoning among opium users in Iran: an emerging health… (10.1186/s13011-017-0127-0)
Abstract ORCID License
125.41 46
17 Integration of substance use disorder services with primary… (10.1186/1747-597x-9-15)
Abstract ORCID License
124.71 45
18 Adherence to methadone maintenance treatment and associated… (10.1186/s13011-017-0115-4)
Abstract ORCID License
124.71 45
19 Parents’ and peers’ normative influence on adolescents’ smok… (10.1186/s13011-017-0089-2)
Abstract ORCID License
123.26 43
20 The role of lifestyle in perpetuating substance use disorder… (10.1186/1747-597x-10-2)
Abstract ORCID License
122.51 42
21 Relapse prevention for addictive behaviors (10.1186/1747-597x-6-17)
Abstract ORCID
122.05 275
22 The opioid crisis: past, present and future policy climate i… (10.1186/s13011-017-0130-5)
Abstract ORCID License
119.33 38
23 Alcohol use disorder severity and reported reasons not to se… (10.1186/s13011-015-0028-z)
Abstract ORCID
117.22 220
24 Examining attrition rates at one specialty addiction treatme… (10.1186/1747-597x-9-41)
Abstract ORCID License
115.81 34
25 Science and policy in substance abuse (10.1186/1747-597x-1-1)
References ORCID License
114.86 33
26 Are adolescents with high socioeconomic status more likely t… (10.1186/1747-597x-5-19)
Abstract ORCID
114.05 190
27 A cost-benefit/cost-effectiveness analysis of proposed super… (10.1186/1747-597x-9-31)
Abstract ORCID License
113.89 32
28 Harms of prescription opioid use in the United States (10.1186/1747-597x-9-43)
Abstract ORCID License
113.89 32
29 Russian roulette with unlicensed fat-burner drug 2,4-dinitro… (10.1186/s13011-015-0034-1)
Abstract ORCID License
113.89 32
30 Psychometric properties of the medical outcomes study: socia… (10.1186/s13011-018-0147-4)
Abstract ORCID License
113.89 32
31 “Nonmedical” prescription opioid use in North America: a cal… (10.1186/1747-597x-8-39)
Abstract ORCID License
112.89 31
32 Usage and perceptions of anabolic-androgenic steroids among… (10.1186/s13011-015-0030-5)
Abstract ORCID License
112.89 31
33 Health and behavioral factors associated with binge drinking… (10.1186/s13011-017-0117-2)
Abstract ORCID License
112.89 31
34 Nowhere to go: How stigma limits the options of female drug… (10.1186/1747-597x-4-10)
Abstract ORCID
112.52 177
35 Physicians discuss the risks of smoking with their patients,… (10.1186/s13011-015-0039-9)
Abstract ORCID License
111.85 30
36 Use of crystal methamphetamine among male adolescents in Cap… (10.1186/s13011-017-0102-9)
Abstract ORCID License
111.85 30
37 Men’s and women’s response to treatment and perceptions of o… (10.1186/s13011-017-0110-9)
Abstract ORCID License
111.85 30
38 Weaved into the cultural fabric: a qualitative exploration o… (10.1186/s13011-018-0146-5)
Abstract ORCID License
111.85 30
39 Brief intervention and decrease of alcohol consumption among… (10.1186/1747-597x-8-31)
Abstract ORCID License
110.78 29
40 Licit and illicit substance use patterns among university st… (10.1186/s13011-017-0128-z)
Abstract ORCID License
110.78 29
41 Chronic pain and opioid misuse: a review of reviews (10.1186/s13011-017-0120-7)
Abstract License
110.48 161
42 The prevalence and significance of substance use disorders i… (10.1186/1747-597x-2-29)
Abstract ORCID
109.79 156
43 Polypharmacy among anabolic-androgenic steroid users: a desc… (10.1186/s13011-015-0006-5)
Abstract ORCID
109.79 156
44 The SALOME study: recruitment experiences in a clinical tria… (10.1186/1747-597x-10-3)
Abstract ORCID License
109.68 28
45 Prevalence and determinants of susceptibility to cigarette s… (10.1186/1747-597x-9-10)
Abstract ORCID License
108.54 27
46 Factors associated with one year retention to methadone main… (10.1186/1747-597x-9-11)
Abstract ORCID License
108.54 27
47 Multi-dimensional self-esteem and substance use among Chines… (10.1186/1747-597x-9-42)
Abstract ORCID License
108.54 27
48 Doping knowledge, attitudes, and practices of Ugandan athlet… (10.1186/s13011-015-0033-2)
Abstract ORCID License
108.54 27
49 Treatment of prescription opioid disorders in Canada: lookin… (10.1186/s13011-016-0055-4)
Abstract ORCID License
108.54 27
50 Psychological drivers in doping: The life-cycle model of per… (10.1186/1747-597x-3-7)
Abstract ORCID
107.46 140